Significant differences in access to tests and treatments for multiple myeloma between public and private systems in Latin America. Results of a Latin American survey. GELAMM (Grupo de Estudio Latino Americano de Mieloma Múltiple)
Riva, Eloísa, Schütz, N., Peña, C., Ruiz-Argüelles, G., Hopkins, C. Rojas, Bove, V., Villano, F., Andino, L., Suárez, L., Martínez, H., Navarro, J., López-Vidal, H., Da Costa, O., Pineda, M. Rodriguez, Rubio, Y., Ramirez, J., Choque, J., Fantl, D.
Published in Annals of hematology (01.05.2020)
Published in Annals of hematology (01.05.2020)
Get full text
Journal Article